Net Cash Provided by (Used in) Operating Activities |
-26.5M |
USD |
-30.3% |
Q1 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q1 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Investing Activities |
14.4M |
USD |
|
Q1 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Q2 2023 |
Q2 2023 |
Common Stock, Shares, Issued |
61.7M |
shares |
-1.06% |
Q2 2023 |
Q2 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q2 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
59.3M |
USD |
-77.9% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Valuation Allowance |
30.8M |
USD |
+228% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Gross |
30.8M |
USD |
+228% |
Q4 2022 |
FY 2022 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-76.1M |
USD |
+61.1% |
Q2 2023 |
Q2 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
14M |
USD |
+61.6% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2023 |
Q2 2023 |
Unrecognized Tax Benefits |
1.27M |
USD |
+166% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2022 |
FY 2022 |
Share-based Payment Arrangement, Expense |
8.88M |
USD |
+40.3% |
Q2 2023 |
Q2 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
Q2 2023 |